THL-mediated gene therapy of experimental PD in the rat was tested with THLs conjugated with the OX26 mouse MAb against the rat TfR, which encapsulated a plasmid DNA that encoded rat tyrosine hydroxylase (TH). Here, TFRC is linked to Parkinson disease.